Arbutus Biopharma ABUS Insider Ownership

NASDAQ ABUS
$5.14 +0.02 (+0.29%)
As of: Sep 4, 2026 · 11:45 AM EDT

Insider Holdings by Owner

3.84Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.015%
0% pp QoQ
Shares Held by Insiders
28.00K
filed for Sep 2026
0.00% QoQ
Shares Outstanding
191.78Mn
191,778,950 shares
Direct Holdings
28.00K
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

ABUS's three largest insider shareholders as of August 29, 2026 are Sciences Ltd. Roivant (TenPercentOwner, 38.85Mn shares), Michael J. Mcelhaugh (Interim President Ceo, 1.66Mn shares), Michael J. Mcelhaugh (Interim President Ceo, 1.66Mn shares).

Form 4 Holdings

Insiders Holding ABUS

Insiders 8
Shares held 3.84Mn
Of outstanding 2.00%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Michael J. Mcelhaugh Interim President Ceo 1,658,003 0 1,658,003 43.1% 19 Feb, 2025
2 Michael J. Sofia Chief Scientific Officer 1,485,121 0 1,485,121 38.6% 05 Feb, 2024
3 William H. Collier President And Ceo 216,500 0 216,500 5.6% 03 Feb, 2023
4 Karen Sims Chief Medical Officer 155,494 0 155,494 4.0% 19 Feb, 2025
5 J. Christopher Naftzger General Counsel And Cco 140,544 0 140,544 3.7% 19 Feb, 2025
6 Elizabeth Howard Evp, Gc, Compliance 86,024 0 86,024 2.2% 03 Feb, 2023
7 Tuan Nguyen Chief Financial Officer 73,500 0 73,500 1.9% 02 Feb, 2026
8 Lindsay Androski President And Ceo 28,000 0 28,000 0.7% 02 Feb, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

442 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
08 Jun, 2026 Roger Sawhney Director Acquired A 78,800 $0.00 $0 78,800 Direct
08 Jun, 2026 Robert A Beardsley Director Acquired A 78,800 $0.00 $0 78,800 Direct
02 Feb, 2026 Tuan Nguyen Chief Financial Officer Acquired A 73,500 $0.00 $0 73,500 Direct
02 Feb, 2026 Tuan Nguyen Chief Financial Officer Acquired A 73,500 $0.00 $0 73,500 Direct
02 Feb, 2026 Tuan Nguyen Chief Financial Officer Acquired A 73,500 $0.00 $0 73,500 Direct
02 Feb, 2026 Lindsay Androski President And Ceo Acquired A 28,000 $0.00 $0 28,000 Direct
02 Feb, 2026 Tuan Nguyen Chief Financial Officer Acquired A 73,500 $0.00 $0 73,500 Direct
02 Feb, 2026 Tuan Nguyen Chief Financial Officer Acquired A 188,400 $0.00 $0 188,400 Direct
02 Feb, 2026 Tuan Nguyen Chief Financial Officer Acquired A 188,400 $0.00 $0 188,400 Direct
02 Feb, 2026 Tuan Nguyen Chief Financial Officer Acquired A 188,400 $0.00 $0 188,400 Direct
02 Feb, 2026 Tuan Nguyen Chief Financial Officer Acquired A 188,400 $0.00 $0 188,400 Direct
02 Feb, 2026 Lindsay Androski President And Ceo Acquired A 71,700 $0.00 $0 71,700 Direct
04 Aug, 2025 Roger Sawhney Director Acquired A 157,600 $0.00 $0 157,600 Direct
31 Mar, 2025 Tuan Nguyen Chief Financial Officer Acquired A 750,000 $0.00 $0 750,000 Direct
31 Mar, 2025 Tuan Nguyen Chief Financial Officer Acquired A 750,000 $0.00 $0 750,000 Direct
31 Mar, 2025 Tuan Nguyen Chief Financial Officer Acquired A 750,000 $0.00 $0 750,000 Direct
31 Mar, 2025 Tuan Nguyen Chief Financial Officer Acquired A 750,000 $0.00 $0 750,000 Direct
31 Mar, 2025 Tuan Nguyen Chief Financial Officer Acquired A 750,000 $0.00 $0 750,000 Direct
31 Mar, 2025 Tuan Nguyen Chief Financial Officer Acquired A 750,000 $0.00 $0 750,000 Direct
31 Mar, 2025 Tuan Nguyen Chief Financial Officer Acquired A 750,000 $0.00 $0 750,000 Direct